Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
111.95
Dollar change
-1.29
Percentage change
-1.14
%
Index- P/E38.42 EPS (ttm)2.91 Insider Own0.02% Shs Outstand3.38B Perf Week-1.73%
Market Cap373.74B Forward P/E26.58 EPS next Y4.21 Insider Trans0.00% Shs Float3.34B Perf Month-3.89%
Income13.04B PEG2.11 EPS next Q0.88 Inst Own10.09% Short Float0.19% Perf Quarter-12.19%
Sales37.40B P/S9.99 EPS this Y23.23% Inst Trans-0.37% Short Ratio1.52 Perf Half Y-9.73%
Book/sh3.66 P/B30.55 EPS next Y25.93% ROA27.68% Short Interest6.36M Perf Year15.93%
Cash/sh2.70 P/C41.51 EPS next 5Y18.21% ROE88.62% 52W Range94.73 - 148.15 Perf YTD8.22%
Dividend Est.1.63 (1.45%) P/FCF31.76 EPS past 5Y16.48% ROI55.28% 52W High-24.43% Beta0.42
Dividend TTM1.45 (1.29%) Quick Ratio0.75 Sales past 5Y14.25% Gross Margin84.53% 52W Low18.18% ATR (14)2.51
Dividend Ex-DateAug 16, 2024 Current Ratio0.94 EPS Y/Y TTM38.33% Oper. Margin43.25% RSI (14)30.69 Volatility2.44% 1.47%
Employees63370 Debt/Eq0.51 Sales Y/Y TTM31.77% Profit Margin34.86% Recom1.94 Target Price145.59
Option/ShortYes / Yes LT Debt/Eq0.46 EPS Q/Q2.79% Payout36.03% Rel Volume1.98 Prev Close113.24
Sales Surprise-0.13% EPS Surprise-7.18% Sales Q/Q23.82% EarningsNov 06 BMO Avg Volume4.19M Price111.95
SMA20-3.61% SMA50-10.22% SMA200-12.71% Trades Volume8,301,428 Change-1.14%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $156
Apr-12-24Initiated BMO Capital Markets Outperform $163
Jan-23-24Initiated Morgan Stanley Overweight $120
Jan-16-24Resumed UBS Neutral
Dec-01-23Initiated Cantor Fitzgerald Overweight $120
Oct-02-23Initiated Argus Buy $110
Jul-14-23Initiated HSBC Securities Buy
Jul-15-22Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-28-22Downgrade UBS Neutral → Sell
Jun-27-22Upgrade Exane BNP Paribas Underperform → Neutral
Today 04:15PM
Oct-30-24 02:32PM
12:57PM
11:22AM
08:30AM
07:18AM Loading…
07:18AM
07:02AM
05:45AM
Oct-29-24 09:18AM
07:05AM
05:07AM
Oct-28-24 05:45PM
04:29PM
09:00AM
08:11AM
04:30AM Loading…
04:30AM
Oct-27-24 11:47AM
10:45AM
Oct-26-24 11:30AM
Oct-25-24 12:37PM
05:00AM
Oct-24-24 01:09PM
01:09PM
11:28AM
10:37AM
09:17AM
06:09AM
Oct-23-24 05:00PM
02:06PM
02:04PM
12:00PM Loading…
12:00PM
11:20AM
08:28AM
05:04AM
Oct-22-24 05:45PM
07:29AM
Oct-21-24 12:32PM
10:47AM
10:26AM
09:55AM
08:50AM
08:47AM
05:26AM
Oct-18-24 01:21PM
05:32AM
Oct-17-24 09:16PM
02:03PM
12:27PM
12:12PM
10:34AM
03:52AM
Oct-16-24 04:21PM
04:19PM
08:00AM
06:15AM
Oct-15-24 05:45PM
12:51PM
09:00AM
Oct-14-24 08:06AM
Oct-13-24 07:15AM
Oct-12-24 02:31PM
Oct-11-24 10:38AM
07:45AM
04:05AM
Oct-10-24 04:39PM
04:39PM
04:39PM
08:03AM
06:45AM
Oct-09-24 05:26PM
01:05PM
10:07AM
09:58AM
07:56AM
05:00AM
Oct-08-24 05:45PM
12:13PM
11:34AM
08:17AM
05:06AM
04:00AM
Oct-07-24 08:10PM
06:44AM
Oct-06-24 06:00AM
Oct-04-24 02:58PM
01:15PM
12:07PM
12:04PM
09:00AM
08:00AM
Oct-03-24 05:00PM
02:46PM
12:33PM
10:45AM
08:24AM
Oct-02-24 09:48AM
05:00AM
Oct-01-24 05:45PM
01:45PM
Sep-30-24 12:29PM
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.